Jim Gabriele is a technology savvy senior executive with more than 30 years’ experience driving growth and leading organizational transformations as a CEO, senior Fortune 50 leader, and entrepreneur. 

Most recently Jim was CEO of M2Gen, an oncology focused portfolio company of PE Firm Clayton, Dubilier and Rice that enables AI driven drug discovery using Big Data.  Jim led the spin out of M2Gen from an academic medical center, transforming it into a commercial organization with a robust pipeline of technology enabled products and services.  

Prior to that, he held senior operating and strategy roles in the Johnson & Johnson Pharmaceutical, Medical Device and Consumer organizations, most recently as Chief Strategy and Analytics Officer of the Global Medical Devices business.

Previously, Jim was Managing Director and COO of Henry Rak Consulting Partners, a successful strategy and analytics company serving global pharmaceutical, medical device and CPG companies. He built the business and sold it to McKinsey & Company, where he went on to serve as a service line Partner. 

Jim earned a B.A. in Economics & Government from the College of William & Mary and an M.B.A. from Harvard Business School. He serves on the advisory board of Finpay Holdings and leads several professional and civic organizations in Valley Forge, Pa., where he resides with his wife Helen and their six children.